Find policies, billing codes, payers, states, and providers
CPT 19105: Ultrasound-Guided Cryoablation of Breast Fibroadenoma
CPT code 19105 covers ultrasound-guided percutaneous cryoablation of a breast fibroadenoma, a minimally invasive procedure that destroys a benign solid breast tumor using a cryoprobe. This code is relevant nationally as clinicians and payers evaluate options that may offer less-invasive alternatives to surgical excision for selected patients with symptomatic or biopsy-proven fibroadenomas. The code signals clinical intent (image-guided ablative therapy) and is important for billing, coverage policy development, and procedure tracking.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and typical sites of service, payer coverage considerations, common modifiers, and guidance on documentation elements linked to the service description. The publication summarizes benchmarks and policy updates where available and highlights areas where explicit payer guidance or national coding consensus may be limited.
The report is intended for clinicians, coding professionals, and policy analysts seeking concise information on coding and clinical context for image-guided percutaneous cryoablation of breast fibroadenomas. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for cpt 19105 policy alerts
Get alerted when payer policies referencing 19105 are released or updated.
Monitor payer policy activity
Billing Code Overview
CPT code 19105 describes a percutaneous cryoablation of a breast fibroadenoma performed under ultrasound guidance. The procedure uses a cryoprobe to destroy a solid, benign breast tumor (fibroadenoma) with image guidance to ensure accurate targeting.
Service type: Image-guided percutaneous ablative procedure
Typical site of service: Outpatient procedure setting, commonly performed in an ambulatory surgery center or hospital outpatient department with ultrasound guidance and local or regional anesthesia.